Copyright
©The Author(s) 2024.
World J Gastroenterol. Jan 14, 2024; 30(2): 184-195
Published online Jan 14, 2024. doi: 10.3748/wjg.v30.i2.184
Published online Jan 14, 2024. doi: 10.3748/wjg.v30.i2.184
Table 5 Characteristics of the susceptibility-guided and empiric treatment groups
| Characteristics | All (n, %) | Susceptibility-guided treatment (n, %) | Empiric treatment (n, %) | P value |
| Age (yr) | 0.448 | |||
| < 50 | 57 (33.7) | 31 (54.4) | 26 (45.6) | |
| ≥ 50 | 112 (66.3) | 54 (48.2) | 58 (51.8) | |
| Gender | 0.812 | |||
| Male | 78 (46.2) | 40 (51.3) | 38 (48.7) | |
| Female | 91 (53.8) | 45 (49.5) | 46 (50.5) |
- Citation: Wang YM, Chen MY, Chen J, Zhang XH, Feng Y, Han YX, Li YL. Success of susceptibility-guided eradication of Helicobacter pylori in a region with high secondary clarithromycin and levofloxacin resistance rates. World J Gastroenterol 2024; 30(2): 184-195
- URL: https://www.wjgnet.com/1007-9327/full/v30/i2/184.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i2.184